FINWIRES · TerminalLIVE
FINWIRES

受全球經濟緊張局勢影響,馬來西亞第一季經濟成長放緩至5.3%。

-- 根據馬來西亞統計局週五公佈的初步估算,馬來西亞經濟第一季成長5.3%,低於上一季的6.3%。 按季度計算,馬來西亞經濟萎縮4.4%,而2025年第四季則成長了3.3%。 服務業、製造業、建築業和農業的成長支撐了供給面的成長,但採礦和採石業有所下滑。 服務業成長5.4%,主要得益於批發零售貿易、資訊通訊以及運輸和倉儲業的推動;製造業成長5.8%,主要得益於關鍵次產業的產出增加。 採礦和採石業因原油和天然氣產量下降而萎縮1.1%;農業成長2.8%,建築業成長7.8%,但成長放緩。 馬來西亞統計局表示,第一季國內生產毛額初步數據將於5月15日公佈。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF